Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Walden Biosciences Announces Presentation at Canaccord Genuity 42nd Annual Growth Conference | ||
By: GlobeNewswire - 04 Aug 2022 | Back to overview list |
|
Presentation to highlight transformational approach to treating kidney diseases CAMBRIDGE, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today announced that Blaine McKee, Ph.D., President and Chief Executive Officer of Walden Biosciences, will be participating in the CG 42nd Annual Growth Conference in Boston from August 8-11, 2022. Dr. McKee will deliver a corporate presentation on August 11, 2022 at 9:30 a.m. Eastern time. About Walden Biosciences Investor Contact: Media Contacts -OR- Helen O’Gorman |
||
|
||
Copyright 2022 GlobeNewswire | Back to overview list |